Skip to main content
Erschienen in: Modern Rheumatology 4/2013

01.07.2013 | Original Article

The mid-term efficacy of intra-articular hyaluronic acid injections on joint structure: a nested case control study

verfasst von: Hiroyuki Oka, Toru Akune, Shigeyuki Muraki, Sakae Tanaka, Hiroshi Kawaguchi, Kozo Nakamura, Noriko Yoshimura

Erschienen in: Modern Rheumatology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

Intra-articular (IA) injection of hyaluronic acid (HA) has been shown to relieve osteoarthritis (OA)-related pain and improve joint structure within a 1-year period. We examined the mid-term (2-year) efficacy of IA–HA in Japanese subjects by using a large-scale population-based cohort of the Research on Osteoarthritis/Osteoporosis Against Disability study.

Methods

We performed a nested case control study of 60 case control pairs matched for age (within 1 year), sex, Kellgren and Lawrence grade, and history of knee pain. The mean follow-up period after IA–HA series was 2.9 years in case patients. We examined the association of IA–HA with knee radiographic severity and knee pain. To estimate radiographic severity of OA, six distinct features—joint space area and the minimum joint space width at medial and lateral sides, osteophyte area, and tibiofemoral angle—were measured using a fully automatic computer-assisted program.

Results

Comparison of the radiographic parameters between case patients and controls showed that the medial and lateral joint space areas were significantly bigger in case patients than in controls. After constructing a multivariate logistic regression model to examine the correlation of knee pain, IA–HA, and radiographic features, we found that unlike radiographic features, IA–HA was protectively associated with the presence of pain.

Conclusion

IA–HA might effectively improve joint structure and relieve pain in patients with knee OA.
Literatur
1.
Zurück zum Zitat Sharma L, Kapoor D. Epidemiology of osteoarthritis. In: Moskowitz RW, Altman RD, Hochberg MC, Buckwalter JA, Goldberg VM, editors. Osteoarthritis: diagnosis and medical/surgical management. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 3–26. Sharma L, Kapoor D. Epidemiology of osteoarthritis. In: Moskowitz RW, Altman RD, Hochberg MC, Buckwalter JA, Goldberg VM, editors. Osteoarthritis: diagnosis and medical/surgical management. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 3–26.
2.
Zurück zum Zitat Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84:351–8.PubMedCrossRef Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84:351–8.PubMedCrossRef
3.
Zurück zum Zitat Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthr Rheum. 1998;41:1343–55.CrossRef Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthr Rheum. 1998;41:1343–55.CrossRef
4.
Zurück zum Zitat Iwata H. Pharmacologic and clinical aspects of intraarticular injection of hyaluronate. Clin Orthop Relat Res. 1993;289:285–91.PubMed Iwata H. Pharmacologic and clinical aspects of intraarticular injection of hyaluronate. Clin Orthop Relat Res. 1993;289:285–91.PubMed
5.
Zurück zum Zitat Caborn D, Rush J, Lanzer W, Parenti D, Murray C. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31:333–43.PubMed Caborn D, Rush J, Lanzer W, Parenti D, Murray C. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31:333–43.PubMed
6.
Zurück zum Zitat Jones AC, Pattrick M, Doherty S, Doherty M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthr Cartil. 1995;3:269–73.PubMedCrossRef Jones AC, Pattrick M, Doherty S, Doherty M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthr Cartil. 1995;3:269–73.PubMedCrossRef
7.
Zurück zum Zitat Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25:2203–12.PubMed Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25:2203–12.PubMed
8.
Zurück zum Zitat Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthr Cartil. 1993;1:97–103.PubMedCrossRef Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthr Cartil. 1993;1:97–103.PubMedCrossRef
9.
Zurück zum Zitat Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006;33:951–6.PubMed Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006;33:951–6.PubMed
10.
Zurück zum Zitat Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthr Cartil. 2002;10:506–17.PubMedCrossRef Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthr Cartil. 2002;10:506–17.PubMedCrossRef
11.
Zurück zum Zitat Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19:265–70.PubMedCrossRef Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19:265–70.PubMedCrossRef
12.
Zurück zum Zitat Waddell DD, Bricker DC. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg. 2006;19:19–27.PubMed Waddell DD, Bricker DC. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg. 2006;19:19–27.PubMed
13.
Zurück zum Zitat Forster MC, Straw R. A prospective randomised trial comparing intra-articular Hyalgan injection and arthroscopic washout for knee osteoarthritis. Knee. 2003;10:291–3.PubMedCrossRef Forster MC, Straw R. A prospective randomised trial comparing intra-articular Hyalgan injection and arthroscopic washout for knee osteoarthritis. Knee. 2003;10:291–3.PubMedCrossRef
14.
Zurück zum Zitat Raman R, Dutta A, Day N, Sharma HK, Shaw CJ, Johnson GV. Efficacy of Hylan G.-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee—a prospective randomized clinical trial. Knee. 2008;15:318–24.PubMedCrossRef Raman R, Dutta A, Day N, Sharma HK, Shaw CJ, Johnson GV. Efficacy of Hylan G.-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee—a prospective randomized clinical trial. Knee. 2008;15:318–24.PubMedCrossRef
15.
Zurück zum Zitat Waddell DD. Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications. Drugs Aging. 2007;24:629–42.PubMedCrossRef Waddell DD. Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications. Drugs Aging. 2007;24:629–42.PubMedCrossRef
16.
Zurück zum Zitat Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;19:CD005321. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;19:CD005321.
17.
Zurück zum Zitat Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil. 2010;18:476–99.PubMedCrossRef Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil. 2010;18:476–99.PubMedCrossRef
18.
Zurück zum Zitat Brandt KD, Smith GN, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis. What is the evidence? Arthr Rheum. 2000;43:1192–203.CrossRef Brandt KD, Smith GN, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis. What is the evidence? Arthr Rheum. 2000;43:1192–203.CrossRef
19.
Zurück zum Zitat Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthr Cartil. 1997;5:153–60.PubMedCrossRef Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthr Cartil. 1997;5:153–60.PubMedCrossRef
20.
Zurück zum Zitat Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500–730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003;57:467–74.PubMed Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500–730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003;57:467–74.PubMed
21.
Zurück zum Zitat Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.PubMedCrossRef Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.PubMedCrossRef
22.
Zurück zum Zitat Altman RD, Hochberg M, Murphy WA Jr, Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthr Cartil. 1995;3(Suppl A):3–70.PubMed Altman RD, Hochberg M, Murphy WA Jr, Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthr Cartil. 1995;3(Suppl A):3–70.PubMed
23.
Zurück zum Zitat Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthr Cartil. 2007;15(Suppl A):A1–56.PubMedCrossRef Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthr Cartil. 2007;15(Suppl A):A1–56.PubMedCrossRef
24.
Zurück zum Zitat Oka H, Muraki S, Akune T, Mabuchi A, Suzuki T, Yoshida H, et al. Fully automatic quantification of knee osteoarthritis severity on plain radiographs. Osteoarthr Cartil. 2008;16:1300–6.PubMedCrossRef Oka H, Muraki S, Akune T, Mabuchi A, Suzuki T, Yoshida H, et al. Fully automatic quantification of knee osteoarthritis severity on plain radiographs. Osteoarthr Cartil. 2008;16:1300–6.PubMedCrossRef
25.
Zurück zum Zitat Muraki S, Oka H, Akune T, Mabuchi A, En-yo Y, Yoshida M, et al. Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthr Cartil. 2009;17:1137–43.PubMedCrossRef Muraki S, Oka H, Akune T, Mabuchi A, En-yo Y, Yoshida M, et al. Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthr Cartil. 2009;17:1137–43.PubMedCrossRef
26.
Zurück zum Zitat Yoshimura N, Muraki S, Oka H, Mabuch A, En-yo Y, Yoshida M, et al. Prevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the Research on Osteoarthritis/Osteoporosis Against Disability (ROAD). J Bone Miner Metab. 2009;27:620–8.PubMedCrossRef Yoshimura N, Muraki S, Oka H, Mabuch A, En-yo Y, Yoshida M, et al. Prevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the Research on Osteoarthritis/Osteoporosis Against Disability (ROAD). J Bone Miner Metab. 2009;27:620–8.PubMedCrossRef
27.
Zurück zum Zitat Muraki S, Oka H, Mabuchi A, Akune T, En-yo Y, Yoshida M, et al. Prevalence of radiographic lumbar spondylosis and its association with low back pain in the elderly of population-based cohorts: the ROAD study. Ann Rheum Dis. 2009;68:1401–6.PubMedCrossRef Muraki S, Oka H, Mabuchi A, Akune T, En-yo Y, Yoshida M, et al. Prevalence of radiographic lumbar spondylosis and its association with low back pain in the elderly of population-based cohorts: the ROAD study. Ann Rheum Dis. 2009;68:1401–6.PubMedCrossRef
28.
Zurück zum Zitat Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Cohort profile: Research on Osteoarthritis/Osteoporosis Against Disability study. Int J Epidemiol. 2010;39:988–95.PubMedCrossRef Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Cohort profile: Research on Osteoarthritis/Osteoporosis Against Disability study. Int J Epidemiol. 2010;39:988–95.PubMedCrossRef
29.
Zurück zum Zitat Caborn D, Rush J, Lanzer W, Parenti D, Murray C. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31:333–43.PubMed Caborn D, Rush J, Lanzer W, Parenti D, Murray C. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31:333–43.PubMed
30.
Zurück zum Zitat Linaker CH, Walker-Bone K, Palmer K, Cooper C. Frequency and impact of regional musculoskeletal disorders. Baillieres Clin Rheumatol. 1999;13:197–215.PubMedCrossRef Linaker CH, Walker-Bone K, Palmer K, Cooper C. Frequency and impact of regional musculoskeletal disorders. Baillieres Clin Rheumatol. 1999;13:197–215.PubMedCrossRef
31.
Zurück zum Zitat Summers MN, Haley WE, Reveille JD, Alarcon GS. Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthr Rheum. 1988;31:204–9.CrossRef Summers MN, Haley WE, Reveille JD, Alarcon GS. Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthr Rheum. 1988;31:204–9.CrossRef
32.
Zurück zum Zitat Cicuttini FM, Baker J, Hart DJ, Spector TD. Association of pain with radiological changes in different compartments and views of the knee joint. Osteoarthr Cartil. 1996;4:143–7.PubMedCrossRef Cicuttini FM, Baker J, Hart DJ, Spector TD. Association of pain with radiological changes in different compartments and views of the knee joint. Osteoarthr Cartil. 1996;4:143–7.PubMedCrossRef
33.
Zurück zum Zitat Wluka AE, Wolfe R, Stuckey S, Cicuttini FM. How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Ann Rheum Dis. 2004;63:264–8.PubMedCrossRef Wluka AE, Wolfe R, Stuckey S, Cicuttini FM. How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Ann Rheum Dis. 2004;63:264–8.PubMedCrossRef
34.
Zurück zum Zitat Day R, Brooks P, Conaghan PG, Petersen M. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31:775–82.PubMed Day R, Brooks P, Conaghan PG, Petersen M. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31:775–82.PubMed
35.
Zurück zum Zitat Shimazu A, Jikko A, Iwamoto M, Koike T, Yan W, Okada Y, et al. Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthr Rheum. 1993;36:247–53.CrossRef Shimazu A, Jikko A, Iwamoto M, Koike T, Yan W, Okada Y, et al. Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthr Rheum. 1993;36:247–53.CrossRef
36.
Zurück zum Zitat Gotoh S, Onaya J, Abe M, Miyazaki K, Hamai A, Horie K, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52:817–22.PubMedCrossRef Gotoh S, Onaya J, Abe M, Miyazaki K, Hamai A, Horie K, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52:817–22.PubMedCrossRef
37.
Zurück zum Zitat Asari A, Miyauchi S, Matsuzaka S, Ito T, Kominami E, Uchiyama Y. Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol. 1998;61:125–35.PubMedCrossRef Asari A, Miyauchi S, Matsuzaka S, Ito T, Kominami E, Uchiyama Y. Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol. 1998;61:125–35.PubMedCrossRef
38.
Zurück zum Zitat Altman RD. Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee. Expert Rev Clin Immunol. 2010;6:21–7.PubMedCrossRef Altman RD. Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee. Expert Rev Clin Immunol. 2010;6:21–7.PubMedCrossRef
Metadaten
Titel
The mid-term efficacy of intra-articular hyaluronic acid injections on joint structure: a nested case control study
verfasst von
Hiroyuki Oka
Toru Akune
Shigeyuki Muraki
Sakae Tanaka
Hiroshi Kawaguchi
Kozo Nakamura
Noriko Yoshimura
Publikationsdatum
01.07.2013
Verlag
Springer Japan
Erschienen in
Modern Rheumatology / Ausgabe 4/2013
Print ISSN: 1439-7595
Elektronische ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-012-0725-7

Weitere Artikel der Ausgabe 4/2013

Modern Rheumatology 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.